Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
103892556 | 10389255 | 6 | F | 1996 | 20160803 | 20140818 | 20160808 | EXP | BR-ROCHE-1176655 | ROCHE | 80.40 | YR | F | Y | 85.00000 | KG | 20160809 | CN | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
103892556 | 10389255 | 1 | PS | RIVOTRIL | CLONAZEPAM | 1 | Unknown | AT NIGHT | RJ1750 | 17533 | 2 | MG | TABLET | QD | |||||
103892556 | 10389255 | 2 | I | RIVOTRIL | CLONAZEPAM | 1 | RJ1750 | 17533 | |||||||||||
103892556 | 10389255 | 3 | I | RIVOTRIL | CLONAZEPAM | 1 | RJ1750 | 17533 | |||||||||||
103892556 | 10389255 | 4 | I | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | IN FASTING | U | 0 | 200 | MG | TABLET | QD | |||||
103892556 | 10389255 | 5 | I | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | AT NIGHT | U | 0 | 40 | MG | TABLET | QD | |||||
103892556 | 10389255 | 6 | SS | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | 17533 | |||||||||||
103892556 | 10389255 | 7 | SS | CLONAZEPAM. | CLONAZEPAM | 1 | 17533 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
103892556 | 10389255 | 1 | Sleep disorder therapy |
103892556 | 10389255 | 2 | Pain |
103892556 | 10389255 | 3 | Anxiety |
103892556 | 10389255 | 4 | Thyroid disorder |
103892556 | 10389255 | 5 | Blood cholesterol abnormal |
103892556 | 10389255 | 6 | Insomnia |
103892556 | 10389255 | 7 | Pain |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
103892556 | 10389255 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
103892556 | 10389255 | Abnormal behaviour | |
103892556 | 10389255 | Blindness | |
103892556 | 10389255 | Blood cholesterol abnormal | |
103892556 | 10389255 | Breast cancer | |
103892556 | 10389255 | Breast injury | |
103892556 | 10389255 | Diabetes mellitus | |
103892556 | 10389255 | Dizziness | |
103892556 | 10389255 | Drug dose omission | |
103892556 | 10389255 | Drug ineffective | |
103892556 | 10389255 | Drug interaction | |
103892556 | 10389255 | Dysgeusia | |
103892556 | 10389255 | Dysstasia | |
103892556 | 10389255 | Eye irritation | |
103892556 | 10389255 | Eye pain | |
103892556 | 10389255 | Fall | |
103892556 | 10389255 | Glaucoma | |
103892556 | 10389255 | Headache | |
103892556 | 10389255 | Hypertension | |
103892556 | 10389255 | Oral discomfort | |
103892556 | 10389255 | Oral pain | |
103892556 | 10389255 | Oropharyngeal pain | |
103892556 | 10389255 | Retinal disorder | |
103892556 | 10389255 | Stomatitis | |
103892556 | 10389255 | Suicidal ideation | |
103892556 | 10389255 | Thyroid disorder | |
103892556 | 10389255 | Visual acuity reduced | |
103892556 | 10389255 | Visual impairment | |
103892556 | 10389255 | Wound |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
103892556 | 10389255 | 1 | 1996 | 0 |